Erythromycin Seromadesis in Orthopedic Surgery

Area of Science:

• Orthopedic Surgery
• Pharmacology
• Sclerotherapy

Background:

• Postoperative seroma is a common complication following surgical procedures.
• Erythromycin, an antibiotic, has demonstrated sclerosing properties in other medical fields.
• Its application in orthopedic surgery for seroma management remains largely unexplored.

Observation:

• A 63-year-old female patient developed a subfascial seroma after femoral prosthesis surgery and total hip replacement.
• The seroma was refractory to conventional treatments, including compression, massage, and surgical intervention.
• Literature review identified erythromycin seromadesis as a potential therapeutic alternative.

Findings:

• Erythromycin seromadesis was administered to the patient with a refractory seroma.
• The treatment resulted in an excellent clinical response, resolving the seroma effectively.
• This case represents a novel application of erythromycin sclerotherapy in an orthopedic context.

Implications:

• Erythromycin sclerotherapy presents a viable and safe treatment option for postoperative seromas in orthopedic and general surgery.
• Further research and clinical studies are warranted to establish robust evidence for its efficacy and safety.
• This approach could offer a new therapeutic avenue for managing challenging seroma cases.